Baker Brothers Advisors - TRAVERE THERAPEUTICS INC ownership

TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 173 filers reported holding TRAVERE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of TRAVERE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$25,767,113
-68.3%
1,225,255
-62.9%
0.16%
-70.9%
Q3 2022$81,312,000
+1.7%
3,300,0090.0%0.53%
+17.4%
Q2 2022$79,959,000
-6.0%
3,300,0090.0%0.45%
-7.2%
Q1 2022$85,041,000
+2.6%
3,300,009
+23.6%
0.49%
+21.3%
Q4 2021$82,847,000
+67.5%
2,669,054
+30.9%
0.40%
+85.7%
Q3 2021$49,464,000
+1713.9%
2,039,772
+991.3%
0.22%
+1708.3%
Q2 2021$2,727,000
-41.6%
186,9150.0%0.01%
-40.0%
Q1 2021$4,667,000186,9150.02%
Other shareholders
TRAVERE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Finepoint Capital LP 895,821$8,008,6403.99%
Deep Track Capital, LP 7,370,000$65,887,8002.54%
VR Adviser, LLC 2,623,677$23,455,6722.47%
Sio Capital Management, LLC 884,770$7,909,8442.45%
Kynam Capital Management, LP 957,502$8,560,0681.40%
MPM BioImpact LLC 552,846$4,942,4431.32%
ARMISTICE CAPITAL, LLC 7,500,000$67,050,0001.03%
Parkman Healthcare Partners LLC 577,494$5,162,7960.95%
Tri Locum Partners LP 251,702$2,250,2160.72%
Cheyne Capital Management (UK) LLP 26,200$234,2280.68%
View complete list of TRAVERE THERAPEUTICS INC shareholders